Korean Market
OWNR
KOREA UNITED PHARM
★

Largest Shareholder Deokyoung Kang's Stake Slightly Drops from 42.17% to 41.90% Due to Related Party's Market Sale, No Impact on Management Control

 
EXCH
KOREA UNITED PHARM
★

Largest Shareholder Stake Dips from 41.86% to 41.59% via Relative's Open Market Sale, Control Impact Limited

 
EXCH
KOREA UNITED PHARM
★★

Korea United Pharm Boosts Shareholder Returns with KRW 610 Dividend and 2.6% Share Cancellation, but Governance Gaps Remain

 
EXCH
KOREA UNITED PHARM
★★

Final Supreme Court Ruling against Korea United in Drug Pricing Lawsuit... Damages of 24.1B KRW Confirmed, 5.3% of Equity

 
PERI
KOREA UNITED PHARM
★★★

Korea United Pharm: Stable Q1 2026 Results, Key Legal Appeal Win, Share Cancellation, and Positive Factors

 
EXCH
KOREA UNITED PHARM
★★★★

Won drug pricing lawsuit appeal, ordered to return 24.1 billion won

 
EXCH
KOREA UNITED PHARM
★

Korea United Pharm, 1Q26 Preliminary: Rev +3.5%, OP -18.3%, NP +10.5%